ClinicalTrials.gg
CompletedNCT04450771Updated Oct 20, 2026Results posted

Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID

An interventional study of Family-based Treatment for ARFID and Manualized Non-Specific Usual Care for ARFID in Avoidant/Restrictive Food Intake Disorder, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 20, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
285
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States — 7 open to participants now, 7 under way, none of them phase 3. Avoidant Restrictive Food Intake Disorder · United States.

Enrollment
2nd of 18
285 · median 38
Started
2020
the only one that year
No phase
17 of 23
5 open now
Registered
4th of 23
by date
Lead sponsor
1 of 23
Stanford University

Among the 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States, this one is the 2nd largest by enrollment of the 18 interventional ones that give a count, is the only one that started in 2020, is one of 17 with no phase, and was the 4th registered.

Avoidant Restrictive Food Intake Disorder

41 studies on the registry are indexed under Avoidant Restrictive Food Intake Disorder; 12 are open to participants now.

Browse Avoidant Restrictive Food Intake Disorder studies →

Open to participants now

7 of the 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 8 Avoidant Restrictive Food Intake Disorder studies recruiting now, 3 set no upper age limit and 4 stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States, or all of them as a file.
02

Study summary

This study is examining the efficacy and mechanism of family therapy compared to usual care for children between the ages of 6 and 12 who are diagnosed with Avoidant/Restrictive Food Intake Disorder. Preliminary data suggest that family therapy is superior to usual care and that improvement in parental self-efficacy related to feeding their children is the mechanism of treatment. In addition, this study will attempt to identify specific patient groups who respond to family therapy.

Read the detailed description

Potential subjects aged 6 years to 12 years, 11 months old with DSM 5 ARFID, and weight equal to or between 75 to 88% EBW who are medically stable for outpatient treatment and their families will be recruited through Stanford University, pediatricians, mental health experts, clinics treating EDs, and local parents' groups. Those eligible for the program will be invited to read and sign informed consent forms and complete the baseline assessment. Participants will then be randomized to FBT-ARFID with medical management for 14 sessions provided over 4 months or manualized Non-Specific Care (NSC) with medical management for 4 months. NSC will consist of 14 sessions over 4 months.

There will be 5 major assessment time points: Baseline, 1 month, 2 months, End Of Treatment (4 months), and 6-month post-treatment Follow-Up. Both the child and the parent will complete measures at these time points. In addition, parents will complete short survey assessments after each of the 14 treatment sessions.

03

Conditions studied

  • Avoidant/Restrictive Food Intake Disorder

Keywords

  • FBT
  • Family Based Treatment
  • ARFID
04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children meeting criteria for ARFID
  • Children between the ages of 6 to 12 years old, living with their families
  • Medically stable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine.
  • Not engaging in another individual or family-based psychotherapy trial during the duration of treatment sessions in the study.
  • Less than 4 sessions of FBT
  • If taking medication for co-morbid disorders, participants must be on a stable dose of medication for 8 weeks (2 months) before participating. If the participant is on a new medication at baseline, but is discontinuing the medication in order to start the study, they must have discontinued the medication before beginning treatment.
  • EBW between 75% and 88%.
  • Able to fluently speak and read English

Exclusion criteria

Exclusion Criteria:

  • Current physical, psychotic illness or other mental illness requiring hospitalization
  • Current psychotic illness or mental retardation or other mental illnesses that would prohibit the use of psychotherapy
  • Current dependence on drugs or alcohol
  • Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight
  • Any medical complications or severe mental disorder (psychosis, low-functioning Autism) that may reduce compliance with the study procedures or require more intensive care to manage the symptoms
  • 4 or more sessions of FBT
  • Currently taking medication for co-morbid disorders that cannot be safely discontinued or prescribed for less than 2 months
  • Medically unstable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine, defined as: vital sign instability (heart rate less than 45 beats per minute), orthostatic blood pressure with changes usually greater than 35 points or findings of gastrointestinal bleeding, dizziness, or syncope, IBW \<75%, hypothermia (body temperature less than 36 degrees centigrade), clinically significant electrolyte abnormalities, or prolonged on
  • Expected Body Weight (EBW) \<75% or > 88%
  • Unable to fluently speak and read English
  • Parent excluded
  • Suicidal
  • In the case of patients with current, or a history of sexual or physical abuse by family members, perpetrators of the abuse will be excluded from treatment.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

QT and QTc

On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.

The study may name a correction formula and a limit in milliseconds, often around 450–480.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
285 participants (actual)

Study arms

  • Experimental
    Family-based Treatment for ARFID(FBT-ARFID)

    FBT-ARFID is a manualized treatment based on the model of FBT that employs the same interventions as standard FBT for AN and BN: externalization, agnosticism, parental empowerment, a behavioral focus on changing eating behavior. Early sessions focus on inciting parents to make changes and include a family meal that allows therapists to observe \& consult directly to mealtime behaviors. FBT-ARFID for children 12 and under is manualized and consists of 2 phases. The first phase is focused on parents taking charge \& changing the eating behaviors of their child that are maintaining ARFID. The second phase focuses on the child taking up in an age-appropriate way managing their eating consistent with the changes the parents have employed in phase 1. Fourteen 1-hour sessions will be conducted approximately weekly over 4 months. Throughout medical monitoring and weekly dietary consultation are available to the family.

    Behavioral: Family-based Treatment for ARFID

  • Active comparator
    Manualized Non-Specific Usual Care for ARFID(NSC)

    A manualized non-specific psycho-educational and motivational enhancement approach that is based on a supportive non-directive psychotherapy model that has been used in other RCTs with eating disorders as a comparison. NSC consists of sessions with the child alone and 5 parent-only meetings. Sessions are 1-hour. NSC matches FBT-ARFID for time and therapist attention. The focus of the NSC intervention is psychoeducation about health \& social impacts of restrictive eating and supporting parent \& child exploration of motivation to change eating patterns \& choices they make about changes to eating. The therapist does not initiate behavioral or cognitive interventions. Feelings about eating and making changes are explored in both the child and parent sessions. Medical and dietary advice are provided weekly.

    Behavioral: Manualized Non-Specific Usual Care for ARFID

Interventions

  • BehavioralFamily-based Treatment for ARFID

    This treatment includes 14 1-hour sessions that will be conducted approximately weekly over a 4 month period. It is a manualized treatment based on the model of FBT that employs the same interventions as standard FBT for AN and BN: externalization, agnosticism, parental empowerment, a behavioral focus on changing eating behavior.

    Also known as: FBT-ARFID

  • BehavioralManualized Non-Specific Usual Care for ARFID

    This treatment is a manualized non-specific psycho-educational and motivational enhancement approach that is based on a supportive non-directive psychotherapy model. It consists of sessions with the child alone and 5 parent-only meetings, all of which are 1-hour over a 4 month period.

    Also known as: NSC

06

What researchers measure

Primary outcomes

  1. Expected Body Weight (EBW)

    Expected Body Weights (EBW) percentages used will be calculated using Center for Disease Control Growth Chart metrics in children and adolescents with weight adjusted for age, gender, and height.

    Time frame: 4 months

  2. Parents Versus Avoidant/Restrictive Food Intake Disorder (ARFID)

    A modification of the Parents versus Anorexia Nervosa Scale, a measure of parental self-efficacy at changing eating behaviors. The modifications to the scale are minor and consisted of changing the name of the disorder named in the scale's questions from AN to ARFID. This is a 7 item 5 point scale (for an overall score range of 7 to 35), where higher scores mean greater parental self-efficacy.

    Time frame: 4 months

  3. Parental Feeding Behavior Assessment

    Meals are recorded by video and then coded for behaviors associated with successful re-feeding using a procedure developed for Family Based Treatment. Criticisms were counts of critical comments to the child. Warmth was counts of positive comments to the child. Physical behaviors were counts of non-verbal praise and support to eat such as rubbing the child's back or loading the child's fork. Directives were counts of direct statements to the child to eat, try a food, or take a bite. Indirectives were statements to the child suggesting that they eat, try a food, or take a bite.

    Time frame: Baseline and week 6

Secondary outcomes

  1. The Pica, ARFID, Rumination Disorder Interview (PARDI)

    The Pica, ARFID, Rumination Disorder Interview (PARDI) is a semi-structured interview designed to diagnose and evaluate symptom severity of Avoidant/Restrictive Food Intake Disorder (ARFID). Parents reported on their child's behavior using the PARDI. The severity score is comprised of 17 items on a 7 point scale (for an overall score range of 0 to 6), where greater scores indicate greater ARFID symptom severity.

    Time frame: All assessment time points (Baseline, 1 month, 2 months, 4 months, and 10-months)

  2. Therapy Suitability and Patient Expectancy (TSPE)

    The Therapy Suitability and Patient Expectancy Scale is a measure with two subscales (Suitability and Success) and 2 items on 11 point scale (for an overall score of 0 to 10 on each subscale) that measures perceptions of the suitability and expectancy of the treatment provided and will be rated by parents. Higher scores on the subscales indicates greater perceptions of suitability and success. There is no TSPE total score.

    Time frame: At the end of session 1 (approximately 1 week following baseline), and end of sessions 3, 5, 7, 9, 11, and 13.

  3. Parenting Style Questionnaire (PSQ)

    The Parenting Style Questionnaire is a 30 item 6 point validated measure of parenting style related to authoritative, authoritarian, and permissive style. This questionnaire is divided up into three subscales: authoritative (13 questions), authoritarian (13 questions), and permissive (4 questions). Each question was rated on a scale of 1 to 6. Item scores in each subscale were summed and averaged to create the subscale score (range: 1 to 6). For all question and subscale scores, greater scores suggest the more preferred parenting style. This questionnaire will be completed by parents/caregivers.

    Time frame: Completed at baseline and 4 months

  4. Center for Epidemiological Studies Depression Scale for Children (CES-DC)

    The Center for Epidemiological Studies Depression Scale for Children is a 20-item 4 point self-report scale (for an overall score range of 0 to 60) that measures child depression, with higher scores suggesting greater depressive symptoms.

    Time frame: Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).

  5. Revised Children's Manifest Anxiety Scale (RCMAS-2) Short

    The Revised Children's Manifest Anxiety Scale Short is a 10 item 2 point scale (for an overall score range of 0 to 10) and is a validated measure of childhood anxiety and will be completed by children, with higher scores suggesting greater anxiety symptoms.

    Time frame: Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).

  6. Helping Alliance Questionnaire (HAQ)

    The HAQ is an 11-item survey, each item scored on a 6 point scale (scores of -3, -2, -1, 1, 2, 3). This questionnaire measures the quality of the therapist-patient relationship. The form is divided up into two subscales: Helpfulness (5 questions for an score range of -15 to 15) and Cooperation (6 questions for a score range of -18 to 18). For each subscale, higher scores correspond to a more positive relationship and perception of the therapist's helpfulness and cooperation. The HAQ will be completed by parents/caregivers.

    Time frame: Completed by parents after treatment sessions 1, 3, 5, 7, 9, 11, and 13, and at major assessment points at 1 month, 2 months, 4 months, and 10-months.

  7. Number of Participants With Disorders Identified Using the Schedule for Affective Disorders and Schizophrenia for School-Aged Children (6-18 Years) (K-SADS)

    The Schedule for Affective Disorders and Schizophrenia for School-Aged Children (K-SADS) is a widely used semi-structured interview detecting psychiatric disorders in children and adolescents. The individual items are scored on a 0 to 3 point rating scale, with scores of a 3 representing threshold criteria that leads to an additional diagnostic supplement based on the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria evidence of the disorder. The K-SADS was administered to ascertain co-morbid psychiatric diagnoses prior to starting treatment.

    Time frame: Completed by parents on behalf of their child at baseline.

  8. Strengths and Difficulties Questionnaire (SDQ)

    The Strengths and Difficulties Questionnaire assesses conduct, social, and peer behaviors consists of 25 items (questions) each rated on a scale from 0 to 2. The SDQ has with 5 subscales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship, and prosocial behavior). Each subscale consists of 5 questions resulting in a subscale score range of 0-10 (higher scores scores correspond to greater difficulties, except for prosocial behavior, where higher scores correspond to fewer difficulties). The total difficulties score is generated by summing scores from all the subscales except prosocial behavior, to create an overall score range of 0-40, where higher scores mean greater difficulties.

    Time frame: Completed by parents at all major assessment points (Baseline, 1 month, 2 months, 4 months, and 10-months).

  9. Beck Depression Inventory (BDI)

    The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression on a 4-point scale (overall scores ranging from 0 to 63). This measure also includes questions about suicidal ideation and intent. Higher scores suggest greater depressive symptoms.

    Time frame: Completed by parents at baseline and 4 months

  10. Beck Anxiety Inventory (BAI)

    The Beck Anxiety Inventory consists of 21 self-reported items assessing a participant's anxiety symptoms on a 4-point (0 to 3) scale (for an overall score range of 0 to 63), where higher scores suggests greater anxiety symptoms.

    Time frame: Completed by parents at baseline and 4 months.

  11. 36-Item Short Form (SF-36)

    The 36-Item Short Form is a 36 item scale and is a general measure of physical and mental health functioning. This form is divided up into 8 subscales: vitality (4 questions), physical functioning (10 questions), bodily pain (2 questions), general health perceptions (5 questions), physical role functioning (4 questions), emotional role functioning (3 questions), social role functioning (2 questions), and mental health (5 questions). 1 question is not included in subscale scoring. The questions range between 2 and 6 points (1 to 2, 1 to 3, 1 to 5, and 1 to 6) and then are each re-coded (scale of 0 to 100), summed, and averaged to create the subscale score (score range of 0 to 100). For all subscales scores, greater scores suggest less disability. This assessment will be taken by the parents/caregivers.

    Time frame: Completed by parents at baseline

  12. Bandura's General Self-Efficacy Scale (GSES)

    Bandura's General Self-Efficacy Scale is a 10-item 4 point self-report scale (for an overall score range of 10 to 40) of general self-efficacy, where higher scores mean higher self-efficacy. This measure was completed by parents for their general self-efficacy score.

    Time frame: Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.

  13. Parental Sense of Competence Scale (PSOC)

    The Parenting Sense of Competence Scale contains 17 items measuring a participant's sense of competence in their parenting skills and as a parent of a child on a 6 scale (for an overall score range of 17 to 102), with higher scores meaning greater parental efficacy.

    Time frame: Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.

07

Results

Posted Oct 20, 2026

Participant flow

This study enrolled family dyads, including children between the ages of 6 and 12 diagnosed with Avoidant/Restrictive Food Intake Disorder (ARFID) and their parent(s) or caregiver(s). The study consisted of 14 weekly sessions that started approximately 1 week after baseline, with separate major assessment time points at baseline, 1 month, 2 months, 4 months (end of treatment) and 10 months (follow up) following start of sessions.

Participant flow — Overall Study
MilestoneFamily-based Treatment for ARFID(FBT-ARFID)Manualized Non-Specific Usual Care for ARFID(NSC)
Started141144
Children who started the study4949
Parents/caregivers who started the study9295
Children who completed the study4848
Parents/caregivers who completed the study9093
Completed138141
Not completed33

Outcome measures

PrimaryExpected Body Weight (EBW)

Expected Body Weights (EBW) percentages used will be calculated using Center for Disease Control Growth Chart metrics in children and adolescents with weight adjusted for age, gender, and height.

Time frame:
4 months
Reported as:
Mean · Percentage of Expected Body Weight
Expected Body Weight (EBW)
Percentage of Expected Body WeightFBT-ARFID - ChildrenManualized Non- Specific Usual Care - Children
Expected Body Weight (EBW)90.21 (88.53 to 91.9)86.81 (85.12 to 88.5)
Statistical analysis
  • FBT-ARFID - Children vs Manualized Non- Specific Usual Care - Children · Longitudinal Analysis · p = <0.0001 (A priori threshold for statistical significance is less than 0.05) · Cohen's d: 0.77 · 95% CI 0.45 to 1.09Longitudinal Linear Mixed Effects Modeling
PrimaryParents Versus Avoidant/Restrictive Food Intake Disorder (ARFID)

A modification of the Parents versus Anorexia Nervosa Scale, a measure of parental self-efficacy at changing eating behaviors. The modifications to the scale are minor and consisted of changing the name of the disorder named in the scale's questions from AN to ARFID. This is a 7 item 5 point scale (for an overall score range of 7 to 35), where higher scores mean greater parental self-efficacy.

Time frame:
4 months
Reported as:
Mean · score on a scale
Parents Versus Avoidant/Restrictive Food Intake Disorder (ARFID)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Parents Versus Avoidant/Restrictive Food Intake Disorder (ARFID)21.63 ± 3.3019.34 ± 2.77
PrimaryParental Feeding Behavior Assessment

Meals are recorded by video and then coded for behaviors associated with successful re-feeding using a procedure developed for Family Based Treatment. Criticisms were counts of critical comments to the child. Warmth was counts of positive comments to the child. Physical behaviors were counts of non-verbal praise and support to eat such as rubbing the child's back or loading the child's fork. Directives were counts of direct statements to the child to eat, try a food, or take a bite. Indirectives were statements to the child suggesting that they eat, try a food, or take a bite.

Time frame:
Baseline and week 6
Reported as:
Mean · behaviors
Parental Feeding Behavior Assessment
behaviorsFBT-ARFID - Parent(s) / Caregiver(s)
Parental Criticism - baseline0.55 ± 0.89
Parental Criticism - week 62.23 ± 4.76
Parental Warmth - baseline1.90 ± 2.27
Parental Warmth - week 64.3 ± 3.83
Parental Physical Encouragement - baseline1.33 ± 2.54
Parental Physical Encouragement - week 63.80 ± 5.50
Parental Indirectives - baseline4.88 ± 3.88
Parental Indirectives - week 68.28 ± 8.40
Parental Directives - baseline4.70 ± 6.67
Parental Directives - week 69.88 ± 14.95
SecondaryThe Pica, ARFID, Rumination Disorder Interview (PARDI)

The Pica, ARFID, Rumination Disorder Interview (PARDI) is a semi-structured interview designed to diagnose and evaluate symptom severity of Avoidant/Restrictive Food Intake Disorder (ARFID). Parents reported on their child's behavior using the PARDI. The severity score is comprised of 17 items on a 7 point scale (for an overall score range of 0 to 6), where greater scores indicate greater ARFID symptom severity.

Time frame:
All assessment time points (Baseline, 1 month, 2 months, 4 months, and 10-months)
Reported as:
Mean · score on a scale
The Pica, ARFID, Rumination Disorder Interview (PARDI)
score on a scaleFBT-ARFID - ChildrenManualized Non-Specific Usual Care for ARFID - Children
Baseline3.02 (2.79 to 3.26)3.15 (2.92 to 3.39)
1 month2.67 (2.41 to 2.93)2.71 (2.49 to 2.93)
2 months2.44 (2.12 to 2.75)2.67 (2.40 to 2.95)
4 months2.37 (2.13 to 2.61)2.67 (2.43 to 2.92)
10 months2.39 (2.13 to 2.65)2.66 (2.39 to 2.92)
SecondaryTherapy Suitability and Patient Expectancy (TSPE)

The Therapy Suitability and Patient Expectancy Scale is a measure with two subscales (Suitability and Success) and 2 items on 11 point scale (for an overall score of 0 to 10 on each subscale) that measures perceptions of the suitability and expectancy of the treatment provided and will be rated by parents. Higher scores on the subscales indicates greater perceptions of suitability and success. There is no TSPE total score.

Time frame:
At the end of session 1 (approximately 1 week following baseline), and end of sessions 3, 5, 7, 9, 11, and 13.
Reported as:
Mean · score on a scale
Therapy Suitability and Patient Expectancy (TSPE)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Suitable - session 16.78 ± 1.746.87 ± 1.82
Suitable - session 36.89 ± 2.206.76 ± 1.82
Suitable - session 56.96 ± 1.626.88 ± 1.78
Suitable - session 76.61 ± 2.076.18 ± 2.14
Suitable - session 96.58 ± 2.285.92 ± 2.20
Suitable - session 116.39 ± 2.496.03 ± 2.29
Suitable - session 136.42 ± 2.446.82 ± 2.39
Successful - session 16.47 ± 1.756.67 ± 1.54
Successful - session 36.60 ± 1.936.51 ± 1.65
Successful - session 56.67 ± 1.686.40 ± 2.03
Successful - session 76.17 ± 1.945.86 ± 2.26
Successful - session 96.20 ± 2.525.33 ± 2.09
Successful - session 115.84 ± 2.514.95 ± 2.18
Successful - session 136.13 ± 2.465.59 ± 2.40
SecondaryParenting Style Questionnaire (PSQ)

The Parenting Style Questionnaire is a 30 item 6 point validated measure of parenting style related to authoritative, authoritarian, and permissive style. This questionnaire is divided up into three subscales: authoritative (13 questions), authoritarian (13 questions), and permissive (4 questions). Each question was rated on a scale of 1 to 6. Item scores in each subscale were summed and averaged to create the subscale score (range: 1 to 6). For all question and subscale scores, greater scores suggest the more preferred parenting style. This questionnaire will be completed by parents/caregivers.

Time frame:
Completed at baseline and 4 months
Reported as:
Mean · score on a scale
Parenting Style Questionnaire (PSQ)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Baseline - Authoritative5.14 ± 0.435.14 ± 0.37
4 months - Authoritative5.13 ± 0.455.16 ± 0.46
Baseline - Authoritarian2.16 ± 0.542.18 ± 0.50
4 months - Authoritarian2.18 ± 0.512.12 ± 0.54
Baseline - Permissive2.55 ± 0.632.62 ± 0.74
4 months - Permissive2.64 ± 0.632.70 ± 0.78
SecondaryCenter for Epidemiological Studies Depression Scale for Children (CES-DC)

The Center for Epidemiological Studies Depression Scale for Children is a 20-item 4 point self-report scale (for an overall score range of 0 to 60) that measures child depression, with higher scores suggesting greater depressive symptoms.

Time frame:
Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
Reported as:
Mean · score on a scale
Center for Epidemiological Studies Depression Scale for Children (CES-DC)
score on a scaleFBT-ARFID - ChildrenManualized Non-Specific Usual Care for ARFID - Children
Baseline15.61 ± 10.2615.66 ± 9.56
1 month13.43 ± 8.6113.45 ± 7.91
2 months10.45 ± 7.5215.09 ± 8.23
4 months10.30 ± 10.1713.65 ± 11.21
10 months11.09 ± 7.9715.37 ± 10.92
SecondaryRevised Children's Manifest Anxiety Scale (RCMAS-2) Short

The Revised Children's Manifest Anxiety Scale Short is a 10 item 2 point scale (for an overall score range of 0 to 10) and is a validated measure of childhood anxiety and will be completed by children, with higher scores suggesting greater anxiety symptoms.

Time frame:
Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
Reported as:
Mean · score on a scale
Revised Children's Manifest Anxiety Scale (RCMAS-2) Short
score on a scaleFBT-ARFID - ChildrenManualized Non-Specific Usual Care for ARFID - Children
Baseline2.70 ± 2.422.84 ± 2.49
1 month2.37 ± 2.462.55 ± 2.50
2 months1.84 ± 2.182.36 ± 2.19
4 months1.81 ± 2.402.49 ± 2.76
10 months1.72 ± 2.282.31 ± 2.28
SecondaryHelping Alliance Questionnaire (HAQ)

The HAQ is an 11-item survey, each item scored on a 6 point scale (scores of -3, -2, -1, 1, 2, 3). This questionnaire measures the quality of the therapist-patient relationship. The form is divided up into two subscales: Helpfulness (5 questions for an score range of -15 to 15) and Cooperation (6 questions for a score range of -18 to 18). For each subscale, higher scores correspond to a more positive relationship and perception of the therapist's helpfulness and cooperation. The HAQ will be completed by parents/caregivers.

Time frame:
Completed by parents after treatment sessions 1, 3, 5, 7, 9, 11, and 13, and at major assessment points at 1 month, 2 months, 4 months, and 10-months.
Reported as:
Mean · score on a scale
Helping Alliance Questionnaire (HAQ)
score on a scaleFBT-ARFID - Parent(s)/ Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s)/ Caregiver(s)
Helpfulness - session 11.63 ± 4.162.12 ± 4.16
Helpfulness - session 34.19 ± 4.551.72 ± 4.35
Helpfulness - 1 month3.98 ± 5.642.07 ± 4.50
Helpfulness - session 55.61 ± 4.192.74 ± 4.60
Helpfulness - session 75.52 ± 4.402.73 ± 4.64
Helpfulness - 2 months5.78 ± 5.141.77 ± 5.57
Helpfulness - session 95.39 ± 5.221.49 ± 5.69
Helpfulness - session 115.83 ± 5.493.41 ± 4.96
Helpfulness - session 136.28 ± 5.845.77 ± 4.93
Helpfulness - 4 months5.45 ± 7.063.90 ± 6.07
Helpfulness - 10 months5.60 ± 7.313.98 ± 5.77
Cooperation - session 19.72 ± 3.279.71 ± 3.13
Cooperation - session 310.81 ± 4.8910.09 ± 3.75
Cooperation - 1 month10.46 ± 5.579.67 ± 3.36
Cooperation - session 511.68 ± 4.4710.92 ± 3.46
Cooperation - session 711.46 ± 3.9210.17 ± 3.56
Cooperation - 2 months11.97 ± 4.398.47 ± 4.81
Cooperation - session 912.03 ± 4.928.62 ± 4.28
Cooperation - session 1112.30 ± 5.0410.32 ± 5.09
Cooperation - session 1312.58 ± 4.7211.93 ± 4.97
Cooperation - 4 months10.68 ± 6.8810.68 ± 5.94
Cooperation - 10 months10.47 ± 6.4410.00 ± 5.18
SecondaryNumber of Participants With Disorders Identified Using the Schedule for Affective Disorders and Schizophrenia for School-Aged Children (6-18 Years) (K-SADS)

The Schedule for Affective Disorders and Schizophrenia for School-Aged Children (K-SADS) is a widely used semi-structured interview detecting psychiatric disorders in children and adolescents. The individual items are scored on a 0 to 3 point rating scale, with scores of a 3 representing threshold criteria that leads to an additional diagnostic supplement based on the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria evidence of the disorder. The K-SADS was administered to ascertain co-morbid psychiatric diagnoses prior to starting treatment.

Time frame:
Completed by parents on behalf of their child at baseline.
Reported as:
Count of participants · Participants
Number of Participants With Disorders Identified Using the Schedule for Affective Disorders and Schizophrenia for School-Aged Children (6-18 Years) (K-SADS)
ParticipantsFBT-ARFID - ChildrenManualized Non-Specific Usual Care for ARFID - Children
Attention Deficit Hyperactivity Disorder1311
Social Anxiety34
Separation Anxiety10
Generalized Anxiety54
Major Depressive Disorder10
Autism Spectrum Disorder23
Obsessive-Compulsive Disorder11
Disruptive Mood Disorder01
Tic35
Oppositional Defiant Disorder66
Phobia34
Tourette12
SecondaryStrengths and Difficulties Questionnaire (SDQ)

The Strengths and Difficulties Questionnaire assesses conduct, social, and peer behaviors consists of 25 items (questions) each rated on a scale from 0 to 2. The SDQ has with 5 subscales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship, and prosocial behavior). Each subscale consists of 5 questions resulting in a subscale score range of 0-10 (higher scores scores correspond to greater difficulties, except for prosocial behavior, where higher scores correspond to fewer difficulties). The total difficulties score is generated by summing scores from all the subscales except prosocial behavior, to create an overall score range of 0-40, where higher scores mean greater difficulties.

Time frame:
Completed by parents at all major assessment points (Baseline, 1 month, 2 months, 4 months, and 10-months).
Reported as:
Mean · score on a scale
Strengths and Difficulties Questionnaire (SDQ)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Emotional Symptoms - baseline3.67 ± 2.173.56 ± 2.11
Emotional Symptoms - 1 month3.93 ± 2.083.22 ± 2.32
Emotional Symptoms - 2 months3.59 ± 2.283.65 ± 2.41
Emotional Symptoms - 4 months3.30 ± 2.363.66 ± 2.33
Emotional Symptoms - 10 months3.21 ± 2.273.33 ± 2.17
Conduct Problems - baseline1.79 ± 1.531.75 ± 1.72
Conduct Problems - 1 month1.92 ± 1.561.80 ± 1.51
Conduct Problems - 2 months2.03 ± 1.681.76 ± 1.55
Conduct Problems - 4 months1.76 ± 1.541.85 ± 1.84
Conduct Problems - 10 months1.88 ± 1.701.73 ± 1.80
Hyperactivity/Inattention - baseline4.91 ± 2.834.61 ± 3.15
Hyperactivity/Inattention - 1 month5.12 ± 2.784.00 ± 3.05
Hyperactivity/Inattention - 2 months4.92 ± 3.154.64 ± 3.06
Hyperactivity/Inattention - 4 months5.02 ± 2.754.63 ± 3.09
Hyperactivity/Inattention - 10 months4.78 ± 2.664.66 ± 3.30
Peer Relationship Problems - baseline2.09 ± 1.682.21 ± 1.95
Peer Relationship Problems - 1 month2.13 ± 1.732.26 ± 2.14
Peer Relationship Problems - 2 months1.84 ± 1.702.32 ± 2.18
Peer Relationship Problems - 4 months1.78 ± 1.632.41 ± 1.99
Peer Relationship Problems - 10 months1.88 ± 1.652.35 ± 1.99
Prosocial Behavior - baseline7.29 ± 1.616.92 ± 2.34
Prosocial Behavior - 1 month7.45 ± 1.796.80 ± 2.55
Prosocial Behavior - 2 months7.41 ± 1.907.43 ± 2.20
Prosocial Behavior - 4 months7.72 ± 1.887.44 ± 2.59
Prosocial Behavior - 10 months7.80 ± 1.787.41 ± 2.47
Total Score - baseline12.49 ± 5.5412.14 ± 6.50
Total Score - 1 month13.10 ± 5.7711.29 ± 6.12
Total Score - 2 months12.40 ± 6.5112.37 ± 5.87
Total Score - 4 months11.87 ± 5.9912.54 ± 6.43
Total Score - 10 months11.76 ± 6.1212.04 ± 6.64
SecondaryBeck Depression Inventory (BDI)

The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression on a 4-point scale (overall scores ranging from 0 to 63). This measure also includes questions about suicidal ideation and intent. Higher scores suggest greater depressive symptoms.

Time frame:
Completed by parents at baseline and 4 months
Reported as:
Mean · score on a scale
Beck Depression Inventory (BDI)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Baseline7.10 ± 6.745.62 ± 3.57
4 months7.39 ± 8.455.51 ± 4.19
SecondaryBeck Anxiety Inventory (BAI)

The Beck Anxiety Inventory consists of 21 self-reported items assessing a participant's anxiety symptoms on a 4-point (0 to 3) scale (for an overall score range of 0 to 63), where higher scores suggests greater anxiety symptoms.

Time frame:
Completed by parents at baseline and 4 months.
Reported as:
Mean · score on a scale
Beck Anxiety Inventory (BAI)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Baseline6.06 ± 7.274.22 ± 3.79
4 months6.13 ± 7.133.93 ± 3.81
Secondary36-Item Short Form (SF-36)

The 36-Item Short Form is a 36 item scale and is a general measure of physical and mental health functioning. This form is divided up into 8 subscales: vitality (4 questions), physical functioning (10 questions), bodily pain (2 questions), general health perceptions (5 questions), physical role functioning (4 questions), emotional role functioning (3 questions), social role functioning (2 questions), and mental health (5 questions). 1 question is not included in subscale scoring. The questions range between 2 and 6 points (1 to 2, 1 to 3, 1 to 5, and 1 to 6) and then are each re-coded (scale of 0 to 100), summed, and averaged to create the subscale score (score range of 0 to 100). For all subscales scores, greater scores suggest less disability. This assessment will be taken by the parents/caregivers.

Time frame:
Completed by parents at baseline
Reported as:
Mean · score on a scale
36-Item Short Form (SF-36)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Vitality52.04 ± 16.6856.31 ± 13.71
Physical Functioning90.10 ± 14.9391.63 ± 14.98
Bodily Pain82.40 ± 16.1484.67 ± 13.93
General Health Perceptions67.95 ± 16.2473.37 ± 11.52
Physical Role Functioning89.03 ± 21.4493.62 ± 11.73
Emotional Role Functioning80.27 ± 27.7888.78 ± 17.23
Social Role Functioning83.55 ± 23.2490.18 ± 11.41
Mental Health72.71 ± 15.7476.29 ± 11.35
SecondaryBandura's General Self-Efficacy Scale (GSES)

Bandura's General Self-Efficacy Scale is a 10-item 4 point self-report scale (for an overall score range of 10 to 40) of general self-efficacy, where higher scores mean higher self-efficacy. This measure was completed by parents for their general self-efficacy score.

Time frame:
Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
Reported as:
Mean · score on a scale
Bandura's General Self-Efficacy Scale (GSES)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Baseline31 ± 2.9532.07 ± 2.42
Session 131.10 ± 3.1831.53 ± 3.06
Session 230.55 ± 3.7431.53 ± 2.97
Session 331.02 ± 4.3131.02 ± 3.13
Session 430.76 ± 4.1831.36 ± 3.30
1 month30.63 ± 4.6231.40 ± 3.00
Session 530.85 ± 4.7031.40 ± 3.12
Session 631.03 ± 4.4131.52 ± 3.17
Session 731.15 ± 4.6531.52 ± 3.08
Session 830.98 ± 4.6331.44 ± 3.16
2 months31.67 ± 4.8831.04 ± 3.03
Session 930.97 ± 4.7530.88 ± 4.19
Session 1031.27 ± 4.9431.48 ± 3.24
Session 1131.37 ± 4.8530.93 ± 2.41
Session 1230.77 ± 4.9231.60 ± 3.13
Session 1330.84 ± 4.8431.31 ± 2.93
Session 1430.40 ± 4.8031.31 ± 3.31
4 months31.84 ± 4.8132.27 ± 3.63
10 months31.89 ± 4.7732.47 ± 3.17
SecondaryParental Sense of Competence Scale (PSOC)

The Parenting Sense of Competence Scale contains 17 items measuring a participant's sense of competence in their parenting skills and as a parent of a child on a 6 scale (for an overall score range of 17 to 102), with higher scores meaning greater parental efficacy.

Time frame:
Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
Reported as:
Mean · score on a scale
Parental Sense of Competence Scale (PSOC)
score on a scaleFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s)
Baseline70.92 ± 8.7970.28 ± 8.59
Session 169.15 ± 10.1770.37 ± 10.31
Session 270.97 ± 9.5570.81 ± 10.18
Session 371.18 ± 9.4371.61 ± 9.80
Session 471.04 ± 9.5170.80 ± 11.34
1 month71.79 ± 9.9170.22 ± 10.66
Session 571.22 ± 8.3472.07 ± 12.53
Session 671.74 ± 9.2071.30 ± 12.26
Session 772.74 ± 9.0173.66 ± 11.11
Session 871.82 ± 10.2872.73 ± 9.81
2 month73.02 ± 10.0871.96 ± 9.14
Session 970.91 ± 10.4172.60 ± 11.88
Session 1072.04 ± 8.7274.43 ± 10.83
Session 1172.08 ± 10.5072.35 ± 10.22
Session 1271.53 ± 9.6372.61 ± 10.67
Session 1372.74 ± 10.5574.21 ± 10.51
Session 1472.31 ± 10.3573.71 ± 9.25
4 months73.29 ± 11.5474.16 ± 11.25
10 months73.71 ± 12.0474.34 ± 8.82

Adverse events

Collected over Pre-treatment (1 week) plus 10 months of weekly sessions and follow-up. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
FBT-ARFID - Children0/49 (0%)1/49 (2%)0/49 (0%)
Manualized Non- Specific Usual Care - Children0/49 (0%)0/49 (0%)0/49 (0%)
FBT-ARFID - Parent(s) / Caregiver(s)0/92 (0%)0/92 (0%)0/92 (0%)
Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)0/95 (0%)0/95 (0%)0/95 (0%)
Most frequent serious events
Most frequent serious events
EventFBT-ARFID - ChildrenManualized Non- Specific Usual Care - ChildrenFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)
PneumoniaRespiratory, thoracic and mediastinal disorders1/490/490/920/95
AsthmaRespiratory, thoracic and mediastinal disorders1/490/490/920/95

Baseline characteristics

Age, Continuous
Age, Continuous(years)FBT-ARFID - ChildrenManualized Non- Specific Usual Care - ChildrenFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)Total
Children9.6 ± 2.09.8 ± 1.9——9.7 ± 2.0
Parent(s) / Caregiver(s)——43.12 ± 6.4944.4 ± 6.3843.78 ± 6.49
Sex: Female, Male
Sex: Female, Male(Participants)FBT-ARFID - ChildrenManualized Non- Specific Usual Care - ChildrenFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)Total
Female17234947136
Male32264343144
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)FBT-ARFID - ChildrenManualized Non- Specific Usual Care - ChildrenFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)Total
Hispanic or Latino13715742
Not Hispanic or Latino36427785240
Unknown or Not Reported00033
Race (NIH/OMB)
Race (NIH/OMB)(Participants)FBT-ARFID - ChildrenManualized Non- Specific Usual Care - ChildrenFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)Total
American Indian or Alaska Native31408
Asian5391431
Native Hawaiian or Other Pacific Islander01012
Black or African American11204
White31337071205
More than one race9107733
Unknown or Not Reported00022
Region of Enrollment
Region of Enrollment(Participants)FBT-ARFID - ChildrenManualized Non- Specific Usual Care - ChildrenFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)Total
United States49499295285
Percentage of Expected Body Weight
Percentage of Expected Body Weight(Percentage of Expected Body Weight)FBT-ARFID - ChildrenManualized Non- Specific Usual Care - ChildrenFBT-ARFID - Parent(s) / Caregiver(s)Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s)Total
Mean84.5 ± 4.284.8 ± 5.0——84.6 ± 4.6
08

Study locations

1 site
  • Stanford University
    Stanford, California 94305, United States
09

References and documents

Publications

  • Lock J, Matheson B, Jo B, Bohon C, Datta N, Whyte A, Boyce H, Gurcan HY, Cogburn AE, Kim B. Family vs Individual Treatment for Children With Avoidant/Restrictive Food Intake Disorder: A Randomized Clinical Trial. J Am Acad Child Adolesc Psychiatry. 2026 Apr 20:S0890-8567(26)00150-4. doi: 10.1016/j.jaac.2026.04.007. Online ahead of print. PubMed 42019720 ↗
  • Van Wye E, Matheson B, Citron K, Yang HJ, Datta N, Bohon C, Lock JD. Protocol for a randomized clinical trial for Avoidant Restrictive Food Intake Disorder (ARFID) in low-weight youth. Contemp Clin Trials. 2023 Jan;124:107036. doi: 10.1016/j.cct.2022.107036. Epub 2022 Nov 29. PubMed 36460266 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2020 to primary completion in Jul 2025, 55 months.

Results were first posted in Oct 2026, 1 year 3 months after primary completion.

Of 16 interventional studies with no phase under Avoidant Restrictive Food Intake Disorder, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 43. This study's 55 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 22, 2020
First posted
Jun 30, 2020
StartActual
Dec 1, 2020
Primary completionActual
Jul 13, 2025
CompletionActual
Jan 16, 2026
Results first posted
Oct 20, 2026
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 20, 2026
Enrollment
98→285
Oct 20, 2026
Primary outcomes
1 edited, 2 time frame changed, 2 description edited
What changed in the outcomes
  • EditedParents versusVersus Avoidant/Restrictive Food Intake Disorder (ARFID)Time frame: Following 4 months of FBT-ARFID or NSC → 4 months
  • Time frameExpected Body Weight (EBW)Following 4 months of FBT-ARFID or NSC → 4 months
  • Time frameParental Feeding Behavior AssessmentAfter week 6 of either arm in all participants. → Baseline and week 6
  • DescriptionExpected Body Weight (EBW): how it is measured was reworded
  • DescriptionParental Feeding Behavior Assessment: how it is measured was reworded
Oct 20, 2026
Documents
Secondary outcomes
4 edited, 9 time frame changed, 9 description edited
What changed in the outcomes
  • EditedRevised Children's Manifest Anxiety Scale (RCMAS-2) ShortTime frame: Completed by children at all major assessment timepoints. → Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
  • EditedHelping RelationshipAlliance Questionnaire (HRQHAQ)Time frame: Completed by parents bi-weekly and at all major assessment points except baseline. → Completed by parents after treatment sessions 1, 3, 5, 7, 9, 11, and 13, and at major assessment points at 1 month, 2 months, 4 months, and 10-months.
  • EditedNumber of Participants With Disorders Identified Using the Schedule for Affective Disorders and Schizophrenia for School-Aged Children (6-18 yearsYears) (K-SADS)Time frame: Completed by parents on behalf of their child at baseline.
  • EditedParental Sense of CompetencyCompetence Scale (PSOC)Time frame: Completed by parents at all major assessments as well as after each of the 14 treatment sessions. → Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
  • Time frameThe Pica, ARFID, Rumination Disorder Interview (PARDI)All assessment time points (BL, 1 month, 2 months, EOT, and 6-month follow-up) → All assessment time points (Baseline, 1 month, 2 months, 4 months, and 10-months)
  • Time frameTherapy Suitability and Patient Expectancy (TSPE)At the end of session 1 and every two weeks during treatment and NSC. → At the end of session 1 (approximately 1 week following baseline), and end of sessions 3, 5, 7, 9, 11, and 13.
  • Time frameParenting Style Questionnaire (PSQ)Completed at baseline and EOT → Completed at baseline and 4 months
  • Time frameCenter for Epidemiological Studies Depression Scale for Children (CES-DC)Completed by children at all major assessment timepoints. → Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
  • Time frameStrengths and Difficulties Questionnaire (SDQ)Completed by parents at all major assessment points. → Completed by parents at all major assessment points (Baseline, 1 month, 2 months, 4 months, and 10-months).
  • Time frameBeck Depression Inventory (BDI)Completed by parents at BL and EOT. → Completed by parents at baseline and 4 months
  • Time frameBeck Anxiety Inventory (BAI)Completed by parents at BL and EOT. → Completed by parents at baseline and 4 months.
  • Time frame36-Item Short Form (SF-36)Completed by parents at BL. → Completed by parents at baseline
  • Time frameBandura's General Self-Efficacy Scale (GSES)Completed by parents at all major assessments as well as after each of the 14 treatment sessions. → Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
  • Description36-Item Short Form (SF-36): how it is measured was reworded
  • DescriptionBandura's General Self-Efficacy Scale (GSES): how it is measured was reworded
  • DescriptionBeck Anxiety Inventory (BAI): how it is measured was reworded
  • DescriptionBeck Depression Inventory (BDI): how it is measured was reworded
  • DescriptionCenter for Epidemiological Studies Depression Scale for Children (CES-DC): how it is measured was reworded
  • DescriptionParenting Style Questionnaire (PSQ): how it is measured was reworded
  • DescriptionStrengths and Difficulties Questionnaire (SDQ): how it is measured was reworded
  • DescriptionThe Pica, ARFID, Rumination Disorder Interview (PARDI): how it is measured was reworded
  • DescriptionTherapy Suitability and Patient Expectancy (TSPE): how it is measured was reworded
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Results posted
    Enrollment 98→285
    Primary outcomes 1 edited, 2 time frame changed, 2 description edited
    What changed in the outcomes
    • EditedParents versusVersus Avoidant/Restrictive Food Intake Disorder (ARFID)Time frame: Following 4 months of FBT-ARFID or NSC → 4 months
    • Time frameExpected Body Weight (EBW)Following 4 months of FBT-ARFID or NSC → 4 months
    • Time frameParental Feeding Behavior AssessmentAfter week 6 of either arm in all participants. → Baseline and week 6
    • DescriptionExpected Body Weight (EBW): how it is measured was reworded
    • DescriptionParental Feeding Behavior Assessment: how it is measured was reworded
    Secondary outcomes 4 edited, 9 time frame changed, 9 description edited
    What changed in the outcomes
    • EditedRevised Children's Manifest Anxiety Scale (RCMAS-2) ShortTime frame: Completed by children at all major assessment timepoints. → Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
    • EditedHelping RelationshipAlliance Questionnaire (HRQHAQ)Time frame: Completed by parents bi-weekly and at all major assessment points except baseline. → Completed by parents after treatment sessions 1, 3, 5, 7, 9, 11, and 13, and at major assessment points at 1 month, 2 months, 4 months, and 10-months.
    • EditedNumber of Participants With Disorders Identified Using the Schedule for Affective Disorders and Schizophrenia for School-Aged Children (6-18 yearsYears) (K-SADS)Time frame: Completed by parents on behalf of their child at baseline.
    • EditedParental Sense of CompetencyCompetence Scale (PSOC)Time frame: Completed by parents at all major assessments as well as after each of the 14 treatment sessions. → Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
    • Time frameThe Pica, ARFID, Rumination Disorder Interview (PARDI)All assessment time points (BL, 1 month, 2 months, EOT, and 6-month follow-up) → All assessment time points (Baseline, 1 month, 2 months, 4 months, and 10-months)
    • Time frameTherapy Suitability and Patient Expectancy (TSPE)At the end of session 1 and every two weeks during treatment and NSC. → At the end of session 1 (approximately 1 week following baseline), and end of sessions 3, 5, 7, 9, 11, and 13.
    • Time frameParenting Style Questionnaire (PSQ)Completed at baseline and EOT → Completed at baseline and 4 months
    • Time frameCenter for Epidemiological Studies Depression Scale for Children (CES-DC)Completed by children at all major assessment timepoints. → Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
    • Time frameStrengths and Difficulties Questionnaire (SDQ)Completed by parents at all major assessment points. → Completed by parents at all major assessment points (Baseline, 1 month, 2 months, 4 months, and 10-months).
    • Time frameBeck Depression Inventory (BDI)Completed by parents at BL and EOT. → Completed by parents at baseline and 4 months
    • Time frameBeck Anxiety Inventory (BAI)Completed by parents at BL and EOT. → Completed by parents at baseline and 4 months.
    • Time frame36-Item Short Form (SF-36)Completed by parents at BL. → Completed by parents at baseline
    • Time frameBandura's General Self-Efficacy Scale (GSES)Completed by parents at all major assessments as well as after each of the 14 treatment sessions. → Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
    • Description36-Item Short Form (SF-36): how it is measured was reworded
    • DescriptionBandura's General Self-Efficacy Scale (GSES): how it is measured was reworded
    • DescriptionBeck Anxiety Inventory (BAI): how it is measured was reworded
    • DescriptionBeck Depression Inventory (BDI): how it is measured was reworded
    • DescriptionCenter for Epidemiological Studies Depression Scale for Children (CES-DC): how it is measured was reworded
    • DescriptionParenting Style Questionnaire (PSQ): how it is measured was reworded
    • DescriptionStrengths and Difficulties Questionnaire (SDQ): how it is measured was reworded
    • DescriptionThe Pica, ARFID, Rumination Disorder Interview (PARDI): how it is measured was reworded
    • DescriptionTherapy Suitability and Patient Expectancy (TSPE): how it is measured was reworded
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04450771
Responsible party
James Dale Lock (Professor of Child Psychiatry and Pediatrics in the Department of Psychiatry and Behavioral Sciences and Director of the Eating Disorder Program for Children and Adolescents, Stanford University) — Principal investigator
First posted
Jun 30, 2020
Start date
Dec 1, 2020
Primary completion
Jul 13, 2025
Completion
Jan 16, 2026
Results posted
Oct 20, 2026
Last update
Oct 20, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion